A method for efficiently preparing montelukast sodium side chain intermediate

CN114605283BActive Publication Date: 2024-11-19SUQIAN SHENGJI MEDICAL TECH CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202210282759.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-03-22
Publication Date
2024-11-19
Estimated Expiration
2042-03-22

Smart Images

  • Figure QLYQS_1
    Figure QLYQS_1
  • Figure QLYQS_2
    Figure QLYQS_2
  • Figure QLYQS_3
    Figure QLYQS_3
Patent Text Reader

Abstract

The present invention relates to the field of medicine, in particular to the field of pharmaceutical technology, and more specifically to a method for efficiently preparing a side chain intermediate of montelukast sodium. By adopting the technical solution disclosed in the present invention, a continuous flow tubular reactor can be applied to the preparation of the side chain intermediate of montelukast sodium, thereby greatly shortening the reaction time. In the preferred technical solution, the reaction time can be controlled within a few hundred seconds, thereby greatly simplifying the reaction steps and shortening the reaction time. At the same time, through the continuous flow reaction process, the target product can be obtained with high yield and high purity. After testing, the purity of the two-step target product can reach 99%, and the yield can reach 98%. The preparation method disclosed in the present invention is a method with few by-products, continuous production, high degree of automation, and good industrial application prospects.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Reactive plasticizer of polyester compound and preparation method and application thereof

    CN107056611A

  • Cyclic sulphate preparation method

    CN108373460A

  • 2, 4, 4-trisubstituted dihydrooxazole derivative and application thereof

    CN111848600A

  • Aryl sulfonamide compounds and uses related thereto

    US20050277649A1

  • Benzothiazole-substituted benzyl alcohols as leukotriene antagonists

    WO1993021169A1